Friday, February 5, 2016
Members of the task force — which will be chaired by Vice President Joe Biden — include the heads of the FDA, HHS, the National Cancer Institute and the National Institutes of Health. The task force, funded by NIH, will present a report to the president before Dec. 31.
Peter Pitts, president and founder of the Center for Medicine in the Public Interest and a former FDA associate commissioner, said the president should ask HHS to appoint an innovation czar to make the most of resources.
Read the White House memorandum here: www.fdanews.com/01-29-16-MoonshotCuresMemo.pdf.
Saturday, December 12, 2015
"4 Days Workshop on In silico Drug Discovery (21st-24th Jan2016)”
Know about drug discovery & optimize your research work
CADD is a rapidly developing branch of chemistry. In the coming days the students who have studied CADD will be required not only in India but across the globe for advanced research and new discovery.The requirement of trained manpower from the discipline such as Chemistry, Biology and Microbiology is the fuel for the growth of CADD. Application of CADD is in areas like Agrochemical, pharmaceutical and biotechnological industries, Computational chemistry and library design groups, Chemical software companies, Database developers, Chemical publishers, In-silico Drug Discovery, Toxicity predictions, ADME prediction of Molecules, Chemicals Vendors , R&D, etc.
On completion of this workshop you will be expertise in:
ü Analyzing chemical fingerprint
ü Generating Knowledge from structure and different chemical databases
ü Using various chemical structure drawing and visualization tools
ü Digitizing your chemical Data.
ü Structure and ligand based vHTS Screening
ü Pharmacophore based Virtual Screening of compounds
ü Docking Studies and Drug Likeness.
ü Hands on training on commercial software’s of Drug discovery
ü Interaction and guidance from eminent scientist from Industry & Academics
ü Training from industry experts from CADD domain.
Prof. Dr. Subhash Padhye
Director, ISTRA, Pune
NIH visiting professor.
Mr. Sameer Chaudhary
RASA Life Science Informatics.
RASA Life Science Informatics
RASA Life Science Informatics
(up to )
21st Dec to 15th Jan 2016
Monday, July 20, 2015
Established in 2011, Bionivid Technology, located in the happening start-up hub of Bangalore, is a genomics and informatics start-up, jointly cofounded by Mr Madavan Vasudevan, Mr Rohit Nandan Shukla and Mr Hitesh Goswami.
Mr Madavan is a qualified microbiologist-turned-bioinformatician; His partner Mr Rohit is also a qualified bioinformatician and a certified programmer; and Mr Hitesh is a neurobiologist with a fine business acumen. All three of them make a perfect ingredient for raising a hot bioinformatics start-up. - See more at: http://www.biospectrumindia.com/biospecindia/features/221910/hot-start-ups-believe-leap-faith#.dpuf
Tuesday, June 23, 2015
Last date for early bird registration
Early bird discount will be awarded
15 Seat (on first come first serve basis )
Thursday, April 30, 2015
The first set of applications that the company has released specifically for genomic analysis include optimized versions of the Broad Institute's Genome Analysis Toolkit; Blast algorithms for nucleotide- and protein-based sequence searching; BWA-ALN, software for mapping low-divergent sequences to a reference genome; and MPI-HMMER, protein sequence analysis software. The company has also released optimized code for AMBER and NAMD, both of which are used for simulating the molecular dynamics of biomolecular systems. The Intel website provides performance numbers for each of the optimized codes as well as directions for how to access and download the tools.
Do you wish to know more?
Life Science and Informatics
is this a new industry?
or a old wine in a new bottle?
Well Life Sciences and Informatics can be anything form computational biology, all omes and omics, core bioinformatics to curation and literature mining, database creation, in the area of biology, chemistry , bio-chem space.
There are number of companies in India and bangalore is the forefront as a major bio-cluster with 20 to 30 companies in this sphere.
now how good are these companies doing?
how good are they in terms of the international markets and how profitable is their business?
what do they do?
These are some interesting things that could be discussed in this blog page...